Professors Susan Graham (Global Health and Medicine) and Jane Simoni (Psychology) have recently received NIH grant support to study consumer and advocate preferences for long-acting injectable HIV therapies in both the United States (Seattle and Atlanta) and Kenya (Nairobi).
These studies are crucial for understanding how medications will be used, what their potential uptake will be, and how to design the most convenient, usable products for people living with HIV. Without such studies, it would be impossible to make the global impact that TLC-ART hopes to achieve with its next generation therapies.
The project is titled “Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and Sub-Saharan Africa” under NIH Grant #R01MH121424.